Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans
Clinical trial NCT04237792 · COMPLETED
Trial details
- NCT number
- NCT04237792
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2021-11-02
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.